The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•5 May 2026•

1 min read

Hoth Therapeutics Receives Nasdaq Non-Compliance Notice Over Bid Price

Key Facts

1Nasdaq notified Hoth Therapeutics of non-compliance with the $1.00 minimum bid price requirement.

2The company has 180 days to regain compliance, with a potential extension or a reverse stock split as options.

Hoth Therapeutics has received a formal deficiency notice from Nasdaq indicating that the company is no longer in compliance with the minimum bid price requirement of $1.00 per share. Under the Nasdaq Capital Market rules, the company has been granted a 180-day grace period to regain compliance and meet the necessary listing standards. To address this issue, the company may consider several strategic options, including a potential reverse stock split or applying for an additional extension period. While the notice does not result in the immediate delisting of the stock (HOTH), it signals potential financial distress to market participants. Investors are closely monitoring the company's ability to boost its share price and maintain its listing status on the exchange.